Psychiatry II Panel - ACCP

80 downloads 190 Views 85KB Size Report
Editorial Board Liaison. Todd P. Semla, Pharm.D., M.S., FCCP, BCPS, AGSF. Clinical Pharmacy Specialist. Benefits Management. U.S. Department of Veteran  ...
Psychiatry II Panel Editorial Board Liaison

Anxiety Disorders

Todd P. Semla, Pharm.D., M.S., FCCP, BCPS, AGSF Clinical Pharmacy Specialist Benefits Management U.S. Department of Veteran Affairs Hines, Illinois Associate Professor Department of Psychiatry and Behavioral Sciences The Feinberg School of Medicine Northwestern University Chicago, Illinois

John J. Battisti, Ph.D., BCPP Assistant Professor Neuropharmacologist Neuroscience Program Mental Health and Behavioral Sciences School of Medicine University of Colorado at Denver Health Sciences Center Clinical Pharmacy Specialist Department of Veterans Affairs Medical Center Denver, Colorado Laura A. Mandos, Pharm.D. Associate Professor of Clinical Pharmacy Department of Pharmacy Practice and Pharmacy Administration University of the Sciences in Philadelphia Philadelphia, Pennsylvania

Authors Tami R. Argo, Pharm.D., M.S., BCPP Clinical Assistant Professor Division of Pharmacy Practice University of Texas at Austin College of Pharmacy Austin, Texas

Linda Gore Martin, Pharm.D., MBA, BCPS Associate Professor, Social and Administrative Pharmacy University of Wyoming School of Pharmacy Laramie, Wyoming

Angela D. Hughes, Pharm.D. Psychiatric Pharmacy Resident College of Pharmacy The University of Texas at Austin Austin, Texas

Substance Use Disorders Christian J. Teter, Pharm.D., BCPP Assistant Professor of Pharmacy Practice Northeastern University School of Pharmacy Boston, Massachusetts Clinical Research Pharmacist Alcohol and Drug Abuse Treatment Program McLean Hospital Belmont, Massachusetts

George A. Kenna, Ph.D., R.Ph. Postdoctoral Research Fellow in Community Health Center for Alcohol and Addiction Studies Brown University Providence, Rhode Island Reviewers

Eric T. Wittbrodt, Pharm.D., FCCP, FCCM, BCPS Medical Education and Research Liaison Medical Affairs, Research and Development TAP Pharmaceutical Products Inc. Lake Forest, Illinois and Associate Professor of Clinical Pharmacy (formerly) Philadelphia College of Pharmacy University of the Sciences in Philadelphia Philadelphia, Pennsylvania

The American College of Clinical Pharmacy and the authors would like to thank the following individuals for their careful review of the Book 3 chapters: Nicola G. Dahl, Pharm.D. Medical Writer Kanab, Utah Mary C. Gurnee, Pharm.D. Pharmacist Consultant Overland Park, Kansas

Pharmacotherapy Self-Assessment Program, 6th Edition

vii

Book 3 Panel

Psychiatry II Panel Substance Use Disorders: Therapeutic Advances for More Complex Diagnoses Todd P. Semla, Pharm.D., M.S., FCCP, BCPS, AGSF Clinical Pharmacy Specialist Benefits Management U.S. Department of Veteran Affairs Hines, Illinois Associate Professor Department of Psychiatry and Behavioral Sciences The Feinberg School of Medicine Northwestern University Chicago, Illinois Christian J. Teter, Pharm.D., BCPP Assistant Professor of Pharmacy Practice Northeastern University School of Pharmacy Boston, Massachusetts Clinical Research Pharmacist Alcohol and Drug Abuse Treatment Program McLean Hospital Belmont, Massachusetts

Book 3 Panel

viii

Pharmacotherapy Self-Assessment Program, 6th Edition